| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/24/2004 | WO2003024386A8 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 06/24/2004 | WO2003022028A3 Methods, reagents, kits and apparatus for protein function analysis |
| 06/24/2004 | WO2003015613A3 Molecular characteristics of non-small cell lung cancer |
| 06/24/2004 | WO2003008560A8 A novel g protein-coupled receptor, gave8 |
| 06/24/2004 | WO2002097390A8 A quantitative hybridization assay for the analysis of nucleic acid |
| 06/24/2004 | WO2002095055A3 Compositions and methods for use in isolation of nucleic acid molecules |
| 06/24/2004 | WO2002086075A3 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 06/24/2004 | WO2002029085A3 Nucleotide detection method |
| 06/24/2004 | WO2001066563A8 T1r taste receptors and genes encoding same |
| 06/24/2004 | US20040122598 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent in food products and cosmetics thereby |
| 06/24/2004 | US20040122222 Instrument and method for collecting nucleic acids |
| 06/24/2004 | US20040122220 Comprises nucleotide sequences coding adipocyte regulatory polypeptide for use in prevention and/or treatment of obesity, diabetes, hypertrophy of cardiac and skeletal muscle, autoimmune and cell proliferative disorders |
| 06/24/2004 | US20040121992 Therapeutic methods of reducing cholesterol accumulation |
| 06/24/2004 | US20040121970 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/24/2004 | US20040121941 Novel inhibitors of prenylated pyrophosphate consuming enzymes |
| 06/24/2004 | US20040121490 Metal chelate containing compositions for use in chemiluminescent assays |
| 06/24/2004 | US20040121460 Pancreatic tissue culture prepared from embryonic stem cells for treatment of panreactic and diabetic disorders |
| 06/24/2004 | US20040121458 Culturable mitochondrial cells with no nucleus, showing mitochondrial activity |
| 06/24/2004 | US20040121424 Identifying presence of gramnegative bacteria via propagation in nutrient broth containing chromogenic compounds at temperature sufficient to support colifom growth and not non-coliform bacterial growth, monitor broth for fluorescent signal |
| 06/24/2004 | US20040121423 preferably a positively charged porous matrix having a negatively charged urea derivative dye on its surface; may further include a peroxide producing signal producing system, e.g., an analyte oxidase and/or peroxidase |
| 06/24/2004 | US20040121421 for screening newborns for homocysteinuria; can be performed on very small quantities of blood; solid phase synthesis |
| 06/24/2004 | US20040121420 and or its precursor GBL (gamma-butyrolactone); test strips utilizing thin layer chromatography in a lateral flow format for drug testing |
| 06/24/2004 | US20040121419 Methods of secretory vimentin detection and modulation |
| 06/24/2004 | US20040121418 Pressure transduced chemical assay and method |
| 06/24/2004 | US20040121411 for monitoring cleavage of beta-amyloid precursor protein (beta APP) by monitoring the fluorescent energy transfer between the adducts; for treating Alzheimer's disease |
| 06/24/2004 | US20040121409 NMR detection of foreign PAS domain ligands |
| 06/24/2004 | US20040121408 Microreactor |
| 06/24/2004 | US20040121404 Staphylococcus aureus-specific detection media and identifying and/or counting method using same |
| 06/24/2004 | US20040121403 Detection and identification of groups of bacteria |
| 06/24/2004 | US20040121402 Electrooptic apparatus which exploits antibody diversity for detection of multiple and rare target particles or antigens |
| 06/24/2004 | US20040121397 Using prostate tissue messenger RNA to detect, diagnose, classify, monitor, prognosticate, prevent or treat cell proliferative disorders of urogenital system |
| 06/24/2004 | US20040121395 Sequence #115 as a target for identifying weight modulating compounds |
| 06/24/2004 | US20040121394 Identifying genetic variance in nucleotide sequences using dideoxyterminators; detection of restriction fragment length polymorphisms and disease diagnosis |
| 06/24/2004 | US20040121393 Using allelic variance in immune response receptors to diagnose and prognose cancer, viral and bacterial infections, glomerulonephritis, sjogren's syndrome and leprosy |
| 06/24/2004 | US20040121390 Using messenger RNA isolated from aberrant or defective tissues as diagnostic probes in disease detection |
| 06/24/2004 | US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/24/2004 | US20040121386 Comprises nucleotide sequences coding mitogen-activated protein kinase kinases 7 (MKK7) for diagnosis and treatment of inflammatory and cancer disorders |
| 06/24/2004 | US20040121384 Identifying defects in protein tyrosine phosphatase gene and diagnosing and treating leukemic blood disorder |
| 06/24/2004 | US20040121382 Multiplexed immunohistochemical assays using molecular tags |
| 06/24/2004 | US20040121381 Identifying calcium channel modulators for treatment of autoimmune, inflammatory, allergenic, asthmatic and cell proliferative disorders |
| 06/24/2004 | US20040121379 Using collagen/gelatin substrate to isolate and preserve cells and nucleotide sequences within cells for use in forensics, genetic counseling or paternity testing |
| 06/24/2004 | US20040121375 Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
| 06/24/2004 | US20040121374 Identifying heterologous and/or homozygous nucleotide sequence mismatches which are associated with restriction fragment length polymorphisms; allelic variation and disease |
| 06/24/2004 | US20040121373 Fragmentation of DNA |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121371 Use of fluorescent moieties and flap endonuclease to quantify and identify preferential nucleotide sequences in mixed solution |
| 06/24/2004 | US20040121370 Novel composition and methods for the treatment of immune related diseases |
| 06/24/2004 | US20040121369 includes a centralized registry that contains protocols and configuration information for both instruments and analysis applications; used to instruct data capture by the biological instruments and direct the analysis of the data |
| 06/24/2004 | US20040121368 having genetic aptitudes beneficial to people such as seeing-eye dogs, disaster rescue dogs, assisting dogs, narcotics detection dogs, watchdogs, and pet dogs; kits |
| 06/24/2004 | US20040121367 Primers and primer sets for use in methods to detect the presence of Acidovorax avenae subsp. citrulli |
| 06/24/2004 | US20040121366 by multi-locus Variable number tandem repeats (VNTR) analysis (MLVA) genotyping system of VNTR identified within the genome; solid phase synthesis; kits |
| 06/24/2004 | US20040121365 Double and triple readout assay systems |
| 06/24/2004 | US20040121364 used to amplify and/or genotype a variety of samples simultaneously for detecting a target sequence; solid phase synthesis |
| 06/24/2004 | US20040121360 Methods, platforms and kits useful for identifying, isolating and utilizing nucleotide sequences which regulate gene exoression in an organism |
| 06/24/2004 | US20040121359 Fluorescence polarisation |
| 06/24/2004 | US20040121356 Microchip |
| 06/24/2004 | US20040121354 System and method for detecting biological and chemical material |
| 06/24/2004 | US20040121352 exhibits substantial acid resistance, allowing the arrays to be treated with low pH solutions; solid phase synthesis |
| 06/24/2004 | US20040121349 Novel 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor |
| 06/24/2004 | US20040121346 Designing and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein by using the same |
| 06/24/2004 | US20040121344 Method of detecting nucleotide polymorphism |
| 06/24/2004 | US20040121343 for rapid, sensitive and specific assays to be used in differentiation of various diseases that are related in terms of one or more clinical characteristics; drug screening |
| 06/24/2004 | US20040121342 including employment of amplification primers having 5' tags to incorporate into amplicons variant nucleotides of interest from target nucleic acids at known ratios, along with the sequences surrounding the variant nucleotides of interest |
| 06/24/2004 | US20040121340 investigational bioinformatics important for determining a proper course of treatment and/or irradication of the bioagent in such cases as biological warfare and facilitating the identification of potential criminal identity |
| 06/24/2004 | US20040121339 comprises a surface coated with a polyelectrolyte-silica or alternating polycationic and polyanionic polymers; can immobilize biological matters by electrostatic and porous adsorptions and potentially hydrogen bonds as well |
| 06/24/2004 | US20040121338 Real-time detection of rolling circle amplification products |
| 06/24/2004 | US20040121337 recognition entity, especially a nucleic acid recognition entity; may have arene units including iptycene units separated by acetylene linkagesbulky substituents to prevent intermolecular pi - pi interactions that can decrease luminosity; |
| 06/24/2004 | US20040121336 Method for generating multiple samples containing a predetermined amount of nucleic acid |
| 06/24/2004 | US20040121335 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS) |
| 06/24/2004 | US20040121332 Gene finding using ordered sets |
| 06/24/2004 | US20040121331 for detecting protein-protein interactions; solid phase synthesis; kits |
| 06/24/2004 | US20040121329 investigational bioinformatics important for determining a proper course of treatment and/or irradication of the bioagent in such cases as biological warfare and facilitating the identification of potential criminal identity |
| 06/24/2004 | US20040121327 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 06/24/2004 | US20040121325 Beta 1,2-xylosyltransferase-gene from arabidopsis |
| 06/24/2004 | US20040121324 Barcoded synthetic lethal screening to identify drug targets |
| 06/24/2004 | US20040121322 Comparative mycobacterial genomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 06/24/2004 | US20040121320 Use of genetic information to detect a predisposition for bone density conditions |
| 06/24/2004 | US20040121319 for diagnosis of disease and genetic predisposition to disease, forensic or paternity testing and genetic analyses, for example breeding or engineering stock improvements in plants and animals |
| 06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
| 06/24/2004 | US20040121315 for rapid detection and characterization of a unique base composition signature (BCS) from environmental, clinical or other samples using polymerase chain reaction (PCR) |
| 06/24/2004 | US20040121314 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS) |
| 06/24/2004 | US20040121313 Methods for rapid detection and identification of bioagents in organs for transplantation |
| 06/24/2004 | US20040121312 Methods for rapid detection and identification of the absence of bioagents |
| 06/24/2004 | US20040121311 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS) |
| 06/24/2004 | US20040121310 Methods for rapid detection and identification of bioagents in forensic studies |
| 06/24/2004 | US20040121309 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS) |
| 06/24/2004 | US20040121306 Method of confirming the presence of myocardial infarction |
| 06/24/2004 | US20040121021 comprises substrate (polyethylene) impregnated with indicator (azo dye) that bleaches at an approximately linear rate in relation to the concentration of ozone in a fluid |
| 06/24/2004 | US20040120957 Use of A33 antigens JAM-it |
| 06/24/2004 | US20040120954 expression of PEX without a catalytic site of MT1-MMP on a cell surface directly prevents an association of two enzymes and inhibits the activation of proMMP-2 in a dose-dependent manner |
| 06/24/2004 | US20040120943 Antithrombotic thrombin variants |
| 06/24/2004 | US20040120939 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 06/24/2004 | US20040120848 Method for manufacturing a sterilized and calibrated biosensor-based medical device |
| 06/24/2004 | US20040118681 bacterial periplasmic binding protein (bPBP) which is not maltose binding protein and at least one reporter group |
| 06/24/2004 | US20040118192 Fluid delivery for scanning probe microscopy |
| 06/24/2004 | US20040118060 Ion channel arrays |
| 06/24/2004 | DE10258258A1 Isolating nucleic acids from liquid samples, for isolating viral nucleic acid from donated blood, by retention on an inorganic oxide carrier, comprises treatment with protease to improve sensitivity and efficiency |
| 06/24/2004 | DE10247478A1 Verfahren zur Bestimmung der enzymatischen Aktivität von Proteinen Method for determining the enzymatic activity of proteins |